Cargando…

Machine Learning Risk Prediction for Incident Heart Failure in Patients With Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) increases the risk of heart failure (HF); however, little focus is placed on the risk stratification for, and prevention of, incident HF in patients with AF. OBJECTIVES: This study aimed to construct and validate a machine learning (ML) prediction model for HF ho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hamatani, Yasuhiro, Nishi, Hidehisa, Iguchi, Moritake, Esato, Masahiro, Tsuji, Hikari, Wada, Hiromichi, Hasegawa, Koji, Ogawa, Hisashi, Abe, Mitsuru, Fukuda, Shunichi, Akao, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700042/ https://www.ncbi.nlm.nih.gov/pubmed/36444329 http://dx.doi.org/10.1016/j.jacasi.2022.07.007

Ejemplares similares

Utility of left ventricular ejection fraction in atrial fibrillation patients without pre‐existing heart failure
por: Hamatani, Yasuhiro, et al.
Publicado: (2023)

Age-dependent risk for thromboembolism in atrial fibrillation: The Fushimi AF registry
por: Esato, Masahiro, et al.
Publicado: (2022)

Clinical Characteristics and Outcomes of Very Elderly Patients With Atrial Fibrillation at High Bleeding Risk　― The Fushimi AF Registry ―
por: Ide, Yuya, et al.
Publicado: (2021)

Predictors for Stroke and Death in Non-Anticoagulated Asian Patients with Atrial Fibrillation: The Fushimi AF Registry
por: Hamatani, Yasuhiro, et al.
Publicado: (2015)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

Fine Fibrillatory Wave as a Risk Factor for Heart Failure Events in Patients With Atrial Fibrillation: The Fushimi Atrial Fibrillation (AF) Registry
por: Kawaji, Tetsuma, et al.
Publicado: (2022)

Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
por: Kobayashi, Kosuke, et al.
Publicado: (2022)

Isometric Handgrip Stress Test during Right Heart Catheterization in Patients with Mitral Regurgitation -A Case Series Study-
por: Hamatani, Yasuhiro, et al.
Publicado: (2021)

Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant
por: Aono, Yuya, et al.
Publicado: (2020)

Clinical significance of ST-segment depression during atrial fibrillation rhythm for subsequent heart failure events
por: Kawaji, Tetsuma, et al.
Publicado: (2023)

Utility of handgrip stress test in patients with functional mitral regurgitation and exertional dyspnoea
por: Hamatani, Yasuhiro, et al.
Publicado: (2020)

Spontaneous coronary artery dissection in a woman undergoing pseudomenopause therapy with leuprorelin: A case report
por: Doi, Kosuke, et al.
Publicado: (2019)

When Should We Start Sodium–Glucose Co-transporter Inhibitors in Patients with Heart Failure? The Importance of Early Intervention
por: Iguchi, Moritake, et al.
Publicado: (2023)

Comprehensive symptom assessment using Integrated Palliative care Outcome Scale in hospitalized heart failure patients
por: Hamatani, Yasuhiro, et al.
Publicado: (2022)

Predictors of Cardioembolic Stroke in Japanese Patients with Atrial Fibrillation in the Fushimi AF Registry
por: Yasuda, Ken, et al.
Publicado: (2018)

Differential response to isometric handgrip depending on the heart failure condition in patients with functional mitral regurgitation: a case report
por: Hamatani, Yasuhiro, et al.
Publicado: (2022)

VEGF‐C and Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2018)

Distinct Characteristics of VEGF‐D and VEGF‐C to Predict Mortality in Patients With Suspected or Known Coronary Artery Disease
por: Wada, Hiromichi, et al.
Publicado: (2020)

Impact of Smoking Status on Growth Differentiation Factor 15 and Mortality in Patients With Suspected or Known Coronary Artery Disease: The ANOX Study
por: Wada, Hiromichi, et al.
Publicado: (2020)

Soluble vascular endothelial growth factor receptor 2 and prognosis in patients with chronic heart failure
por: Iguchi, Moritake, et al.
Publicado: (2021)

Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED‐J Study
por: Wada, Hiromichi, et al.
Publicado: (2022)

Clinical Features and Prognosis in Patients with Atrial Fibrillation and Prior Stroke: Comparing the Fushimi and Darlington AF Registries
por: Ogawa, Hisashi, et al.
Publicado: (2017)

Local abnormal atrial activity related to right septal intra-atrial reentrant tachycardia after mitral valve surgery
por: An, Yoshimori, et al.
Publicado: (2021)

Atrial fibrillation and stroke prevention: state of the art—epidemiology and pathophysiology: new risk factors, concepts and controversies
por: Kodani, Eitaro, et al.
Publicado: (2020)

Risk Factors Associated With Ischemic Stroke in Japanese Patients With Nonvalvular Atrial Fibrillation
por: Okumura, Ken, et al.
Publicado: (2020)

Distinct Characteristics of Circulating Vascular Endothelial Growth Factor-A and C Levels in Human Subjects
por: Wada, Hiromichi, et al.
Publicado: (2011)

Calcineurin-GATA-6 pathway is involved in smooth muscle–specific transcription
por: Wada, Hiromichi, et al.
Publicado: (2002)

Time-dependent Changes of Atherosclerotic LDL Complexes after Smoking Cessation
por: Komiyama, Maki, et al.
Publicado: (2016)

Rivaroxaban Monotherapy in Patients With Atrial Fibrillation and Coronary Stenting at Multiple Vessels or the Left Main Trunk: The AFIRE Trial Subanalysis
por: Ishii, Mitsuru, et al.
Publicado: (2022)

Ischemic Stroke in Acute Decompensated Heart Failure: From the KCHF Registry
por: Iguchi, Moritake, et al.
Publicado: (2021)

Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF
por: Kodani, Eitaro, et al.
Publicado: (2022)

Study design of GENERAL (general practitioners and embolism prevention in NVAF patients treated with rivaroxaban: Real-life evidence): A multicenter prospective cohort study in primary care physicians to investigate the effectiveness and safety of rivaroxaban in Japanese patients with NVAF
por: Kusano, Kengo, et al.
Publicado: (2017)

Computed tomography model-based treatment of atrial fibrillation and atrial macro-re-entrant tachycardia
por: Piorkowski, Christopher, et al.
Publicado: (2008)

The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
por: Komiyama, Maki, et al.
Publicado: (2014)

Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
por: Komiyama, Maki, et al.
Publicado: (2017)

A multicenter prospective cohort study to investigate the effectiveness and safety of apixaban in Japanese elderly atrial fibrillation patients (J‐ELD AF Registry)
por: Okumura, Ken, et al.
Publicado: (2019)

Rivaroxaban Underdose for Atrial Fibrillation with Stable Coronary Disease: The AFIRE Trial Findings
por: Arashi, Hiroyuki, et al.
Publicado: (2022)

International Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial Descriptives
por: Hsu, Jonathan C., et al.
Publicado: (2016)

Outcomes and Safety of Very-Low-Dose Edoxaban in Frail Patients With Atrial Fibrillation in the ELDERCARE-AF Randomized Clinical Trial
por: Akashi, Shintaro, et al.
Publicado: (2022)

A case of successful radiofrequency catheter ablation for atrial tachycardia originating from the inferior vena cava using high-resolution mapping
por: Fukumoto, Yusaku, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u6796scqujcsl98p9e0suovmva